|
Main
|
|
Note: This record shows only the 20 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
17 October 2012 |
|
Main ID: |
NCT01185912 |
|
Date of registration:
|
24/06/2010 |
|
Primary sponsor: |
|
|
Public title:
|
Cardiomyocyte Apoptosis Following Antegrade and Retrograde Cardioplegia
|
|
Scientific title:
|
|
|
Date of first enrolment:
|
August 2010 |
|
Target sample size:
|
20 |
|
Recruitment status: |
Completed |
|
URL:
|
http://clinicaltrials.gov/show/NCT01185912 |
|
Study type:
|
Observational |
|
Study design:
|
Observational Model: Case Control, Time Perspective: Prospective
|
|
|
Countries of recruitment
|
|
Finland
| | | | | | | |
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- aortic valve stenosis or combined aortic valve disease
Exclusion Criteria:
- angiographically verified hemodynamically significant coronary artery disease
impaired left ventricular function (left ventricular ejection fraction <50%) surgery
including additional procedures other than aortic valve replacement cancer
Age minimum:
60 Years
Age maximum:
90 Years
Gender:
Both
|
|
Health Condition(s) or Problem(s) studied
|
|
Cardiomyocyte Apoptosis
|
|
Intervention(s)
|
|
Procedure: Ventricle muscle tissue samples
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|